statistiche ricercatore

Continente	#
NA - Nord America	523
AS - Asia	307
EU - Europa	270
SA - Sud America	82
Continente sconosciuto - Info sul continente non disponibili	27
AF - Africa	20
OC - Oceania	3
Totale	1.232

Nazione	#
US - Stati Uniti d'America	498
CN - Cina	116
SG - Singapore	88
BR - Brasile	64
IE - Irlanda	53
IT - Italia	53
DE - Germania	40
RU - Federazione Russa	39
HK - Hong Kong	31
VN - Vietnam	26
FI - Finlandia	19
FR - Francia	14
GB - Regno Unito	14
CA - Canada	10
ZA - Sudafrica	10
BD - Bangladesh	7
IN - India	7
UA - Ucraina	7
SE - Svezia	6
IQ - Iraq	5
PL - Polonia	5
BE - Belgio	4
JP - Giappone	4
TR - Turchia	4
VE - Venezuela	4
CL - Cile	3
EC - Ecuador	3
ES - Italia	3
GT - Guatemala	3
ID - Indonesia	3
IL - Israele	3
MX - Messico	3
NL - Olanda	3
SA - Arabia Saudita	3
AR - Argentina	2
AT - Austria	2
AU - Australia	2
AZ - Azerbaigian	2
BO - Bolivia	2
DO - Repubblica Dominicana	2
MA - Marocco	2
NI - Nicaragua	2
PK - Pakistan	2
PY - Paraguay	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
BH - Bahrain	1
BY - Bielorussia	1
CO - Colombia	1
CR - Costa Rica	1
CW - ???statistics.table.value.countryCode.CW???	1
DK - Danimarca	1
DZ - Algeria	1
EG - Egitto	1
ET - Etiopia	1
GH - Ghana	1
GP - Guadalupe	1
GY - Guiana	1
HN - Honduras	1
HR - Croazia	1
HU - Ungheria	1
KE - Kenya	1
KR - Corea	1
LB - Libano	1
LT - Lituania	1
LV - Lettonia	1
LY - Libia	1
MU - Mauritius	1
NZ - Nuova Zelanda	1
PH - Filippine	1
RO - Romania	1
RS - Serbia	1
SC - Seychelles	1
SV - El Salvador	1
TT - Trinidad e Tobago	1
Totale	1.206

Nome	#
Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase DprE1.	191
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia	158
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2 P95-mutated neoplasms	157
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis.	141
Clinical significance of somatic mutation in unexplained blood cytopenia	131
Relationship between clone metrics and clinical outcome in clonal cytopenia	121
Incidence and Prognosis of Clonal Hematopoiesis in patients with Chronic Idiopathic Neutropenia	112
Disclosing the impact of carcinogenic SF3b mutations on pre-mRNA recognition via all-atom simulations	110
Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity	83
Distinct routes of clonal progression in SF3B1-mutant myelodysplastic syndromes	15
null	13
Totale	1.232

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	29	0	0	0	0	0	3	0	1	4	0	4	17
2022/2023	150	12	13	2	8	11	7	0	10	74	0	12	1
2023/2024	84	10	17	4	7	6	18	0	7	0	2	3	10
2024/2025	243	10	10	11	10	21	32	26	17	45	13	16	32
2025/2026	470	31	27	43	53	82	30	68	20	48	41	17	10
2026/2027	136	4	18	24	46	44	0	0	0	0	0	0	0
Totale													1.232